Bal Pharma Limited has informed the Exchange about Copy of Newspaper Publication of Unaudited financial results of the Company for the quarter ended 31.12.2025.
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma Limited has submitted to the exchange a copy of the newspaper publication carrying its unaudited financial results for the quarter ended 31 December 2025 (Q3 of the financial year ending March 2026). This is a routine regulatory compliance filing under SEBI and stock exchange rules, which require listed companies to publish their quarterly results in at least one English and one regional language newspaper within 48 hours of declaring them. No specific financial numbers, revenue figures, or profit/loss details are included in this particular filing.
This filing is procedural and does not by itself contain new financial data; actual Q3 numbers would have been disclosed in the earlier results filing. Shareholders should refer to the previously submitted financial results document for detailed revenue, profit, and margin figures.